ArticlePDF Available

Feline chronic gingivostomatitis with calicivirus infection

Authors:

Abstract

Feline chronic gingivostomatitis (FCGS) is an oral inflammatory condition that frequently affects felines. Its etiology is not well defined, but several viral agents are thought to be involved. Several therapeutic protocols have been described, yet treatment response is often variable, and the therapeutic success is transient with an unpredictable duration. Therefore, the therapeutic strategy needs to be tailored for each patient. This work relates a case characterized by viral involvement in its etiopathogenesis providing an alternative to the most widely-used methods that so often frustrate both veterinary doctors and pet owners.
CASE REPORT
Braz. J. Vet. Res. Anim. Sci., São Paulo, v. 55, n. 3, p. 1-5, e141344, 2018
DOI: 10.11606/issn.1678-4456.bjvras.2018.141344
Feline chronic gingivostomatitis with calicivirus infection: case
report
Gengivostomatite crônica felina com infecção por calicivírus: relato de caso
Aline Silvestrini da SILVA1; Fernanda Campos HERTEL1; Mayara Pereira LOTÉRIO1; Jéssica Miranda COTA1;
Bruna Giannakopoulos RODRIGUES2; Marcus Rebouças SANTOS1; Emily Correna Carlo REIS3
1 Universidade Federal de Viçosa, Programa de Pós-Graduação em Medicina Veterinária, Viçosa – MG, Brazil
2 Universidade Federal de Viçosa, Programa de Residência em Medicina Veterinária, Viçosa – MG, Brazil
3 Universidade Federal de Viçosa, Departamento de Medicina Veterinária, Viçosa – MG, Brazil
Abstract
Feline chronic gingivostomatitis (FCGS) is an oral inflammatory condition that frequently affects felines. Its etiology is not well
defined, but several viral agents are thought to be involved. Several therapeutic protocols have been described, yet treatment
response is often variable, and the therapeutic success is transient with an unpredictable duration. Therefore, the therapeutic
strategy needs to be tailored for each patient. This work relates a case characterized by viral involvement in its etiopathogenesis
providing an alternative to the most widely-used methods that so often frustrate both veterinary doctors and pet owners.
Keywords: Feline chronic gingivostomatitis. Feline. Interferon. Calicivirus.
Resumo
A gengivostomatite crônica felina (FCGS) é uma condição inflamatória oral que frequentemente afeta felinos. A sua etiologia
não está bem definida, mas acredita-se que vários agentes virais possam estar envolvidos. Muitos protocolos terapêuticos têm
sido descritos, no entanto, a resposta ao tratamento é frequentemente variável e o sucesso terapêutico é transitório com uma
duração imprevisível. Portanto, a estratégia terapêutica precisa ser adaptada para cada paciente. O presente trabalho propõe a
caracterização do envolvimento viral na etiopatogenia da doença como uma alternativa aos métodos mais amplamente
utilizados, que muitas vezes frustram médicos veterinários e os donos de animais de estimação.
Palavras-chave: Gengivostomatite crônica felina. Felinos. Interferon. Calicivírus.
Feline chronic gingivostomatitis (FCGS) is a
chronic oral inflammatory condition that frequently
affects felines (LYON, 2005). Its etiology is not well
defined, but the immune system is thought to be
involved in its pathogenesis (VEIR et al., 2002;
LYON, 2005). Several therapeutic protocols are
described with medical and/or surgical approaches.
Clinical studies point to the involvement of several
viral agents in FCGS etiopathogenesis, including
feline calicivirus (FCV) (LYON, 2005).
A 12-year-old female domestic shorthair cat had
a history of weight loss, hyporexia and tooth loss
beginning approximately two months before
presenting to our practice. Physical examination
revealed the presence of ulcers in the oral cavity
(Figure 1), mostly localized on the swollen gums and
tonsils, in addition to pain upon palpation and
mouth opening. The cat also presented dental
calculus on all teeth. Complementary tests were
performed, hyperproteinemia was driven by
hyperglobulinemia, and the FIV/FeLV immune-
Correspondence to:
Aline Silvestrini da Silva
Universidade Federal de Viçosa, Departamento de Medicina
Veterinária
Avenida Peter Henry Rolfs, s/n
CEP 36570- 900, Viçosa, MG, Brazil
e-mail: aline.silvestrini1804@gmail.com
Received: 11/12/2017
Approved: 07/08/2018
| 2
Braz. J. Vet. Res. Anim. Sci., São Paulo, v. 55, n. 3, p. 1-5, e141344, 2018
assay was negative for both viruses. Antibiotic
therapy with amoxicillin and potassium clavulanate
(20 mg/kg, twice per day for 21 days) was prescribed
along with prednisolone (1 mg/kg, twice per day for
seven days, followed by a gradual dose reduction) for
initial reduction of swollen tonsils, combined with
periodontal therapy. The treatment temporarily
improved the clinical symptoms. Due to the
recurrent relapses after treatment with antibiotics
and corticosteroid was discontinued, premolar and
molar teeth extraction and oral cavity biopsy
procedures were performed, and the animal was
prescribed ketoprofen (1 mg/kg, once per day for 5
days) for pain management as well as the antibiotic
therapy as previously prescribed.
The histopathological findings revealed the
presence of dense lymphoplasmacytic and
polymorphonuclear inflammatory infiltrate in the
gingival mucosa. Therefore, based on clinical signs
and treatment response, the presumptive diagnosis
of FCGS was confirmed.
Although a follow-up appointment after one
week was recommended, the patient returned two
months after exodontia, presenting hyporexia and
recurrence of the lesions (Figure 2), combined with
dysphagia and sialorrhea. A sample was collected by
sterile gingival swab of the injured areas of oral
cavity. Viral isolation was performed through
inoculation in cell culture, considered the gold
standard in virological diagnosis (Laboratory of
Immunobiological and Animal Virology,
Department of Veterinary - UFV). After
multiplication in cultured cells, the virus was
identified by the cytopathic characteristics of feline
calicivirus present in the sample (Figure 3), which
were compatible with FCV isolation. The patient
returned with complaints of sialorrhea, hyporexia
and dehydration. Upon examination of the oral
cavity, the recurrence of lesions in the gingiva and in
the region of the palatoglossal arch was observed.
Treatment with amoxicillin and clavulanate was
prescribed, and the patient was requested to return
for a follow-up assessment. After four days, the
patient returned with general improvement of the
clinical symptoms and return to normorexia.
Interferon alfa 2A (30 IU/animal, once daily for 7
days) was prescribed with a seven-day interval
without medication until further recommendations.
At submission of this case report, the patient had
been successfully treated with interferon alfa 2A
with an improvement in general condition, and no
subsequent lesions have been observed.
The mucosa of the oral cavity is always exposed
to antigens (VEIR et al., 2002). The immune system
produces antibodies against the antigens, leading to
the activation of the complement system, attracting
phagocytic cells that damage the membranes of
gingival cells (WHITE et al., 1992).
It is common for periodontal disease to occur
concomitant with FCGS lesions. Studies suggest an
association between FCGS and the bacteria involved
in periodontal disease because many affected
animals respond to antibiotic therapy (WHITE et
al., 1992). The patient was initially treated with
antibiotics and corticosteroids, together with the
removal of dental calculi to treat the concomitant
periodontal disease. This resulted in improvement
of clinical signs and symptoms for a short period of
time (NIZA et al., 2004). As the clinical treatment
was not sufficient to keep the animal asymptomatic,
the option was surgical treatment (BELLEI et al.,
2008). Even with extraction of premolar and molar
teeth, the patient returned due to recurrence of the
lesions, an occurrence that is not uncommon. This
fact is reported by Jennings et al. (2015) in a
retrospective study of feline stomatitis, where 67% of
the patients improved with dental extraction, but
most required medical management with
antimicrobial, anti-inflammatory, or analgesic
medications following tooth extraction. Other
| 3
Braz. J. Vet. Res. Anim. Sci., São Paulo, v. 55, n. 3, p. 1-5, e141344, 2018
authors also report that extraction of teeth showed
better results, and clinical cure could reach 50-60%
of the cases. About 20% of the patients presented
persistent caudal discrete stomatitis, but benefited
from the fact that symptoms almost disappeared,
culminating in a better quality of life. Initially,
extraction of premolar and molar teeth is chosen,
but if there is no satisfactory answer, all teeth are
extracted (BELLEI et al., 2008; HOFMANN-
APPOLLO et al., 2010; HUNG et al., 2014).
Figure 1 – Presence of ulcers in the oral cavity of a cat with
Feline chronic gingivostomatitis
Figure 2 – Recurrence of the lesions in cat with Feline
chronic gingivostomatitis
Figure 3 – A) Normal cell culture; B) Cytopathic characteristics of feline calicivirus present in the sample collected from
a cat with Feline chronic gingivostomatitis
| 4
Braz. J. Vet. Res. Anim. Sci., São Paulo, v. 55, n. 3, p. 1-5, e141344, 2018
Corticosteroids are widely used in the treatment
of FCGS, but controversy exists related to their use.
In cases with viral involvement, administration of
corticosteroids may contribute to the development
and progression of the disease, and their therapeutic
efficacy decreases over time (NIZA et al., 2004).
Diagnosis is based on patient history, including
progression of the condition, duration of symptoms
and results obtained with previously established
therapy. Physical examination with inspection of the
oral cavity is crucial, but laboratory findings may
also be used, often indicating persistent neutropenia
and hyperglobulinemia (HENNET, 2005; LYON,
2005). Histopathological examination is the gold
standard (LYON, 2005).
Currently, the disease can be treated with
different therapeutic protocols associated or not
with the surgical treatment. Several drugs have
already been used in treatment and responses differ
for each animal. Until now, no treatment has been
shown to be totally effective in promoting disease
cure, only the control of clinical signs (HOFMANN-
APPOLLO et al., 2010).
Considering disease recurrence, refractory
response to treatment and findings of
complementary examinations, total exodontia
combined with immunomodulatory medication and
antibiotic therapy was recommended to prolong the
patient’s life. As interferon has antiviral,
antiproliferative and immunomodulatory effects
that regulate inflammatory processes (NIZA et
al., 2004), a different approach was chosen using
interferon alfa 2A together with periodic control of
plaque accumulation on incisive and canine teeth
with successful results and no subsequent
recurrence of lesions. This is in agreement with a
previously reported case that describes clinical
improvement and reduction of lesions using
immunomodulatory therapy in two cats with FCGS
(LEAL et al., 2013). This treatment has several
advantages, including: (i) decreased number of
surgical procedures, (ii) maintenance of canine teeth
that are important for feline behavior, (iii) avoiding
continuous use of antibiotics in line with worldwide
recommendations for the control of bacterial
resistance and the effect on normal microbiota in the
animal’s gastrointestinal tract and, (iv) promising
results of better life-long symptom control.
The animal was treated several times with
antibiotics and immunosuppressive therapy as it
presented recurrence of the disease even after
extraction of premolar and molar teeth. The owner
made treatment decisions more difficult by failing to
return to the clinic for follow-up appointments on
the dates required to adjust the treatment and
selection of drugs. This case reports successful
immunomodulatory therapy with interferon alfa 2A
after extraction of all premolar and molar teeth,
established based on the inflammatory nature of the
disease and its association with a viral infection.
References
BELLEI, E.; DALLA, F.; MASETTI, L.; PISONI, L.;
JOECHLER, M. Surgical therapy in chronic feline
gingivostomatitis (FCGS). Veterinary Research
Communications, v. 32, p. 231-234, 2008. Supplement 1.
doi: 10.1007/s11259-008-9153-8.
HENNET, P. Relationship between oral calicivirus and
herpesvirus carriage and “palatoglossitis” lesions. In:
ANNUAL VETERINARY DENTAL FORUM & WORLD
VETERINARY DENTAL CONGRESS, 9, 2005, Orlando.
Proceedings… Orlando: Academy of Veterinary Dentistry,
American Veterinary Dental College, American Veterinary
Dental Society, p. 503, 2005.
HOFMANN-APPOLLO, F.; CARVALHO, V. G. G.; GIOSO,
M. A. Complexo gengivite estomatite-faringite dos felinos.
Clínica Veterinária, v. 15, n. 84, p. 44-52, 2010.
| 5
Braz. J. Vet. Res. Anim. Sci., São Paulo, v. 55, n. 3, p. 1-5, e141344, 2018
HUNG, Y. P.; YANG, Y. P.; WANG, H. C.; LIAO, J. W.;
HSU, W. L.; CHANG, C. C.; CHANG, S. G. Bovine
lactoferrin and piroxicam as an adjunct treatment for
lymphocytic plasmacytic gingivitis stomatitis in cats.
Veterinary Journal, v. 202, n. 1, p. 76-82, 2014.
doi: 10.1016/j.tvjl.2014.06.006.
JENNINGS, M. W.; LEWIS, J. R.; SOLTERO-RIVERA, M.
M.; BROWN, D. C.; REITE, A. M. Effect of tooth extraction
on stomatitis in cats: 95 cases (2000-2013). Journal of the
American Veterinary Medical Association, v. 246, n. 6, p.
654-660, 2015. doi: 10.2460/javma.246.6.654.
LEAL, R. O.; GIL, S.; BRITO, M. T. V.; MCGAHIE, D.;
NIZA, M. M. R. E.; TAVARES, L. The use of oral
recombinant feline interferon omega in two cats with type II
diabetes mellitus and concurrent feline chronic
gingivostomatitis syndrome. Irish Veterinary Journal, v. 66,
n. 19, p. 1-4, 2013. doi: 10.1186/2046-0481-66-19.
LYON, K. F. Gingivostomatitis. Veterinary Clinics of North
America: Small Animal Practice, v. 35, n. 4, p. 891-911, 2005.
doi: 10.1016/j.cvsm.2005.02.001.
NIZA, M. M. R. E.; MESTRINHO, L. A.; VILELA, C. L.
Gengivo-estomatite crónica felina um desafio clínico.
Revista Portuguesa de Ciências Veterinárias, v. 99, n. 551,
p. 127-135, 2004.
VEIR, J. K.; LAPPIN, M. R.; FOLEY, J. E.; GETZY, D. M.
Feline inflammatory polyps: historical, clinical, and PCR
findings for feline calicivirus and feline herpes virus-1 in 28
cases. Journal of Feline Medicine and Surgery, v. 4, n. 4, p.
195-199, 2002. doi: 10.1053/jfms.2002.0172.
WHITE, S. D.; ROSYCHUK, R. A. W.; JANIK, T. A.;
DENEROLLE, P.; SCHULTHEISS, P. Plasma cell stomatitis-
pharyngitis in cats: 40 cases (1973-1991). Journal of the
American Veterinary Medical Association, v. 200, n. 9, p.
1377-1380, 1992.
... 4), які болючі та інколи кровоточать. Такі виразки можуть траплятися і на слизових оболонках гортані (Rolim et al., 2017;Thomas et al., 2017;Druet & Hennet, 2017;Da Silva et al., 2018;Nakanishi et al., 2019;Fried et al., 2021). ...
Article
Full-text available
Cat breeding has become very popular nowadays. The presence of these animals in catteries, especially in conditions of imperfect compliance with sanitary and hygienic requirements, often causes outbreaks of viral diseases, the causative agents of which are transmitted mainly by the aerogenic transmission mechanism. Calicivirosis is the most common kennel disease; it can occur as a mono-infection and can also be associated with other viral respiratory diseases. The study aimed to evaluate the epizootic features and clinical course of feline calicivirus in catteries. It was found that the disease's stationary focus was in the experimental cattery. Depending on the year's season, the morbidity increase begins in April, peaks (40 %) in July, and gradually decreases until September. The most vulnerable age group is kittens aged 2–6 months due to imperfect immune mechanisms at this age. The disease occurs mainly manifestly in this age group, with characteristic pronounced clinical signs. Sick cats have sub febrile or pyretic fever, lack of appetite, and salivation with viscous saliva. Ulcers develop on the mucous membranes of the oral cavity. Also, erosions and ulcers are noted in the nasal mirror and on the mucous membrane of the larynx. There was conjunctivitis with serous to catarrhal-purulent exudate. Laboratory tests revealed leukopenia, acceleration of erythrocyte sedimentation rate, left shift of the nucleus, lymphocytosis, and monocytosis, which indirectly determine the viral disease and stimulation of immune functions, and the development of a systemic inflammatory response. Biochemical tests revealed the development of intoxication syndrome, hepatitis liver failure, and renal failure. The data obtained prove the systemic nature of the impact of calicivirus infection, the development of complications in the form of a systemic inflammatory response, which affects various organs and systems, particularly the liver and excretory system. The development of multiorgan pathology in feline calicivirus infection requires an integrated approach to treatment, including pathogenetic and symptomatic measures in the treatment protocol.
... Recovery following treatment of a case of Feline calicivirus with gingivo-stomatitis was reported by da Silva et al. (2018). The chosen therapy in this case was multiple antibiotics and immunomodulatory with interferonalpha 2A. ...
Article
Full-text available
The purpose of this case study was to describesthe infection withfeline calicivirus manifested aschronic stomatitis, rhinitisand otitis ina Bengal cat. Acat was presented to the clinic due to inappetence, weakness, and frequent vomiting. It hadnever been vaccinated, and never been given anthelmintic. It had an openwound on itsback,andpurulent dischargewas appearing inthe earand nose. Usingan antigen testkit, Feline Calicivirus was tested positivefor infection with Feline calicivirus.Therapies were givento relieve clinical signshowever, thepatient could not be saved. Prevention of feline caliciviruscould be done by vaccination, as well as maintainingcleanliness of housingand equipment
Conference Paper
Full-text available
The aim of this study is to determine the effect of parenteral recombinant human interferon (rHuIFN)-α2a administration on rectal temperature, respiratory rate, pulse rate, hemogram and blood gas parameters in healthy sheep. In this study, 9.000.000 IU rHuIFN-α2a was administered subcutaneously in 10 Merinos sheep. Blood samples were taken before (0 hours) and after at 4., 8., 12., 24., 48., 72., 96. and 120. hours. Rectal temperature, respiratory rate and pulse rate were determined at the same sampling times. Hemogram and blood gas parameters were measured with hemocell counter and blood gas analyzer, respectively. Increases in rectal temperature and pO2 levels (p<0.05) were determined, while decreases in potassium and ionized calcium levels (p<0.05) were measured. Statistically (p<0.05) fluctuations were determined in pulse rate, total leukocytes, pH, Base (ecf) and sodium values. In conclusion, it can be stated that single dose rHuIFN-α2a application to sheep does not cause significant physiological side effects other than mild fever.
Article
Full-text available
Abstract Aim: The primary aim of this study was to determine the effect of parenteral recombinant human interferon (rHuIFN)-α2a administration on serum tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-10 levels in healthy sheep. In addition, the main physiological parameters (rectal temperature, pulse rate, respiratory rate), hemogram and blood gas parameters were determined, as well. Materials and Methods: In this study, 9.000.000 IU rHuIFN-α2a was administered subcutaneously in 10 Merinos sheep. Blood samples were taken before (0 hours) and after at 4, 8, 12, 24, 48, 72, 96 and 120 hours. Rectal temperature, pulse and respiratory rate were also determined at the same sampling times. Sheep-specific TNF-α, IL-6 and IL-10 levels were determined from serum samples by the ELISA reader. Hemogram and blood gas parameters were measured by complete blood cell counter and blood gas analyzer, respectively. Results: After rHuIFN-α2a treatment, TNF-α and IL-10 concentrations reached peak levels (p<0.05) at the 96 hours, whereas the IL-6 level did not change in a statistically significant (p>0.05). On the other hand, a temporary increase in rectal temperature and pO2 levels (p<0.05) were determined, while decreased potassium and ionized calcium levels (p<0.05) were measured. Statistically significantly (p<0.05) fluctuations were determined in pulse rate, white blood cell counts, pH, base(ecf) and sodium values. Conclusion: It may be stated that administration of rHuIFN-α2a showed immunological effects in sheep, as it is generally accepted as safe and can be considered for use in treatment.
Article
Full-text available
Feline lymphocytic-plasmacytic gingivitis/stomatitis (LPGS) or caudal stomatitis is an inflammatory disease that causes painfully erosive lesions and proliferations of the oral mucosa. The disease is difficult to cure and can affect cats at an early age, resulting in lifetime therapy. In this study, a new treatment using a combination of bovine lactoferrin (bLf) oral spray and oral piroxicam was investigated using a randomized double-blinded clinical trial in 13 cats with caudal stomatitis. Oral lesion grading and scoring of clinical signs were conducted during and after the trial to assess treatment outcome. Oral mucosal biopsies were used to evaluate histological changes during and after treatment. Clinical signs were significantly improved in 77% of the cats. In a 4-week study, clinical signs were considerably ameliorated by oral piroxicam during the first 2 weeks. In a 12-week study, the combined bLf oral spray and piroxicam, when compared to piroxicam alone, exhibited an enhanced effect that reduced the severity of the oral lesions (P = 0.059), while also significantly improving clinical signs (P < 0.05), quality of life (P < 0.05), and weight gain (P < 0.05). The remission of oral inflammation was closely correlated with the decreased number of macrophages (OR = 4.719, P <0 .05). There was no detectable influence on liver or kidney function during a 12-week assessment. It was concluded that combining oral bLf spray and piroxicam was safe and might be used to decrease the clinical signs of caudal stomatitis in cats.
Article
Full-text available
Feline Chronic Gingivostomatitis Syndrome (FCGS) is a common disease in clinical practice. Among the therapeutic options available, long-acting corticosteroids are frequently used due to their anti-inflammatory and immunosuppressive properties. Although they may improve the clinical symptoms, they can lead to a progressive form of the disease that becomes refractory to treatment. Furthermore, their direct relationship with type II diabetes mellitus (DM) is well known. Consequently, these drugs are controversial and not recommended for routine management of FCGS. Recombinant feline interferon-omega (rFeIFN-omega) is an immunomodulatory compound. Recently, its daily oral administration has been shown to be successful in treating refractory cases of FCGS. This case study describes two clinical cases of type II DM complicated by FCGS. Both animals were calicivirus positive and they had been previously treated with long-acting corticosteroids, which may have been the major cause of DM. The two cats were treated with glargine insulin (Lantus, starting dose 1 IU/cat twice daily (BID)), achieving remission 10 and 18 weeks later respectively. Considering the difficulty with control of FCGS in these animals, an oral daily dose of rFeIFN-omega was started as an alternative to long-acting corticosteroids. In both cats oral clinical signs gradually improved and 60 days after the start of therapy the owners reported a significant relief of pain during mastication. According to the authors' knowledge, this is the first case report that describes the successful use of rFeIFN-omega in the management of FCGS in type II diabetic cats, in which long-acting corticosteroids are contraindicated.
Article
Objective: To evaluate long-term response of cats with stomatitis to tooth extraction. Design: Retrospective case series. Animals: 95 cats with stomatitis. Procedures: Medical records of cats with stomatitis that was treated with tooth extraction during a 14-year period were reviewed. Demographic information and diagnostic results were recorded as well as surgical procedure, including full-mouth extraction (FME) versus partial-mouth extraction (PME), and specifics of medical management. Patients were categorized according to response to treatment. Results: Median postoperative follow-up time was 231 days (range, 33 to 2,655 days). Of 95 cats, 6 (6.3%) had no improvement and 25 (26.3%) had little improvement in stomatitis following tooth extraction and extended medical management (EMM). Following tooth extraction, 37 (39.0%) cats had substantial clinical improvement and 27 (28.4%) cats had complete resolution of stomatitis; of these 64 cats, 44 (68.8%) required EMM for a finite period to achieve positive outcomes. Extent of tooth extraction (PME vs FME) was not associated with overall response to treatment. At initial recheck examination, a better long-term response to tooth extraction was observed in patients with resolution of abnormal behavior (OR, 7.2), decrease in oral inflammation (OR, 3.5), and lack of need for follow-up medical management with antimicrobials (OR, 3.7). Conclusions and clinical relevance: Extraction of teeth in areas of oral inflammation provided substantial improvement or complete resolution of stomatitis in more than two-thirds of affected cats. Full-mouth extraction did not appear to provide additional benefit over PME. Most cats with stomatitis may require EMM to achieve substantial clinical improvement or complete resolution.
Article
Clinical signs, laboratory findings, and treatment results of 40 cats with the histologic diagnosis of plasma cell stomatitis-pharyngitis are discussed. Median age was 7.1 years, with no discernable sex predilection. Anorexia and difficulty prehending food were the most common clinical signs. Hyperproteinemia with associated hyperglobulinemia was the most common laboratory finding. Of various treatments, administration of corticosteroids or injectable gold (aurothioglucose) proved most effective in controlling the clinical signs.
Article
Inflammatory polyps are associated with significant aural or nasopharyngeal disease in cats. It has been proposed that chronic viral infection may induce the masses. Ventral bulla osteotomy (VBO) is usually recommended for definitive therapy but removal of masses from the nasopharynx or external ear canal by traction/avulsion is also used. A retrospective study of 28 cats with inflammatory polyps was conducted to correlate recurrence with mode of therapy. Tissues from 41 polyps were assayed for feline calicivirus and feline herpesvirus-1 by RT-PCR and PCR, respectively. Of the 14 cats initially treated by traction/avulsion, recurrence was detected in five of nine cats with radiographic evidence of bulla disease but none of the cats with normal bullae. Traction/avulsion is a reasonable treatment for inflammatory polyps if the bullae are radiographically normal. Failure to detect feline calicivirus and feline herpesvirus-1 suggests that tissue persistence of these viruses is not associated with the development of inflammatory polyps.
Article
Gingivostomatitis (GS) with various patterns of disease may require antiviral therapy, steroids, laser fulguration, immunomodulation drugs, or nonsteroidal anti-inflammatory drugs. The use of cyclosporine as an immunomodulation drug has long-term benefits in reduction of the immunologic events that contribute to GS. Whole-mouth extraction or partial extraction (premolars and molars), with radiographic conformation that all root remnants have been removed, may be the most viable option in nonresponsive and or intractably painful stomatitis in noncompliant cats or dogs. Oral inflammation subsided after extraction without the need for further medication in approximately 70% of the cats from two studies with previous chronic unrelenting oral disease. The combination of immunomodulation with cyclosporine together with laser resection of proliferative tissue should be recommended if extraction of teeth is not desired. Removal of proliferative oral tissues by lasing (carbon dioxide laser) removes the tissue that maybe producing tissue antigens and the area where bacteria are sequestered. The use of anti-inflammatory medications is recommended in the management of GS. Therapeutic success is achieved when there is elimination of proliferative tissue and inflammation.
Gengivo-estomatite crónica felina -um desafio clínico
  • M M R E Niza
  • L A Mestrinho
  • C L Vilela
NIZA, M. M. R. E.; MESTRINHO, L. A.; VILELA, C. L. Gengivo-estomatite crónica felina -um desafio clínico.
Relationship between oral calicivirus and herpesvirus carriage and "palatoglossitis" lesions
  • P Hennet
HENNET, P. Relationship between oral calicivirus and herpesvirus carriage and "palatoglossitis" lesions. In: ANNUAL VETERINARY DENTAL FORUM & WORLD VETERINARY DENTAL CONGRESS, 9, 2005, Orlando. Proceedings… Orlando: Academy of Veterinary Dentistry, American Veterinary Dental College, American Veterinary Dental Society, p. 503, 2005.
Complexo gengivite estomatite-faringite dos felinos. Clínica Veterinária, v. 15, n. 84
  • F Hofmann-Appollo
  • V G G Carvalho
  • M A Gioso
HOFMANN-APPOLLO, F.; CARVALHO, V. G. G.; GIOSO, M. A. Complexo gengivite estomatite-faringite dos felinos. Clínica Veterinária, v. 15, n. 84, p. 44-52, 2010.